SEGMENT INFORMATION (Tables)

9 Months Ended

Sep. 26, 2025

Segment results for the three months ended September 26, 2025 are shown below ($ in millions):


	Total		Intelligent Operating Solutions		Advanced Healthcare Solutions		Unallocated Corporate Costs and Other
Sales	$	1,027.1	$	698.8	$	328.3	$	—
Cost of sales	(377.9)		(241.3)		(136.6)		—
Gross profit	649.2		457.5		191.7		—
Operating expenses	(489.6)		(276.8)		(149.2)		(63.6)

Operating profit (loss)	159.6		180.7		42.5		(63.6)
Non-operating income (expense), net
Interest expense, net	(25.4)		—		—		(25.4)

Other non-operating income (expense), net	0.8		—		—		0.8
Earnings from continuing operations before income taxes	$	135.0	$	180.7	$	42.5	$	(88.2)

Depreciation and amortization expenses	$	(109.1)	$	(59.1)	$	(49.6)	$	(0.4)

Capital expenditure	$	(28.6)	$	(22.7)	$	(5.9)	$	—

Segment results for the three-month period ended September 27, 2024 are shown below ($ in millions):


	Total		Intelligent Operating Solutions		Advanced Healthcare Solutions		Unallocated Corporate Costs and Other
Sales	$	1,003.7	$	681.3	$	322.4	$	—
Cost of sales	(362.2)		(227.6)		(134.6)		—
Gross profit	641.5		453.7		187.8		—
Operating expenses	(469.5)		(284.7)		(151.1)		(33.7)
Operating profit (loss)	172.0		169.0		36.7		(33.7)
Non-operating income (expense), net
Interest expense, net	(37.1)		—		—		(37.1)
Other non-operating income (expense), net	(25.8)		—		—		(25.8)
Earnings from continuing operations before income taxes	$	109.1	$	169.0	$	36.7	$	(96.6)

Depreciation and amortization expenses	$	(107.8)	$	(57.6)	$	(49.9)	$	(0.3)

Capital expenditure	$	(21.6)	$	(17.3)	$	(4.0)	$	(0.3)

Segment results for the nine-month period ended September 26, 2025 are shown below ($ in millions):


	Total		Intelligent Operating Solutions		Advanced Healthcare Solutions		Unallocated Corporate Costs and Other
Sales	$	3,036.6	$	2,086.6	$	950.0	$	—
Cost of sales	(1,104.4)		(713.7)		(390.7)		—
Gross profit	1,932.2		1,372.9		559.3		—
Operating expenses	(1,437.5)		(846.8)		(459.3)		(131.4)

Operating profit (loss)	494.7		526.1		100.0		(131.4)
Non-operating income (expense), net
Interest expense, net	(89.5)		—		—		(89.5)

Other non-operating income (expense), net	3.1		—		—		3.1
Earnings from continuing operations before income taxes	$	408.3	$	526.1	$	100.0	$	(217.8)

Depreciation and amortization expenses	$	(326.3)	$	(175.9)	$	(149.4)	$	(1.0)

Capital expenditure	$	(74.7)	$	(59.8)	$	(14.8)	$	(0.1)

Segment results for the nine-month period ended September 27, 2024 are shown below ($ in millions):


	Total		Intelligent Operating Solutions		Advanced Healthcare Solutions		Unallocated Corporate Costs and Other
Sales	$	3,008.1	$	2,062.3	$	945.8	$	—
Cost of sales	(1,084.5)		(688.6)		(395.9)		—
Gross profit	1,923.6		1,373.7		549.9		—
Operating expenses	(1,419.5)		(866.5)		(454.1)		(98.9)
Operating profit (loss)	504.1		507.2		95.8		(98.9)
Non-operating income (expense), net
Interest expense, net	(119.8)		—		—		(119.8)
Other non-operating income (expense), net	(58.2)		—		—		(58.2)
Earnings from continuing operations before income taxes	$	326.1	$	507.2	$	95.8	$	(276.9)

Depreciation and amortization expenses	$	(322.8)	$	(172.0)	$	(150.4)	$	(0.4)

Capital expenditure	$	(63.5)	$	(50.9)	$	(9.8)	$	(2.8)

Segment Assets:


	As of
($ in millions)	September 26, 2025		December 31, 2024
Intelligent Operating Solutions	$	6,315.4	$	6,324.1
Advanced Healthcare Solutions	4,907.1		5,008.6
Total segment assets	11,222.5		11,332.7
Other (a)	607.8		967.9
Assets of Discontinued Operations	56.4		4,715.5
Total assets	$	11,886.7	$	17,016.1

(a) Other represents corporate assets which consist primarily of cash, property, plant, and equipment, and net deferred income tax assets.